CDP-DG(a-13:0/a-15:0) (BioCAD00000110287)

{$topic}

Metabolite Card

Formula: C40H73N3O15P2 (897.4517)
SMILES: [H][C@@](COC(=O)CCCCCCCCC(C)CC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCC(C)CC

Synonyms [en]

CDP-DG(a-13:0/a-15:0); [(2R)-1-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3-(10-methyldodecanoyloxy)propan-2-yl] 12-methyltetradecanoate; CDP-diacylglycerol(a-13:0/a-15:0); {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(12-methyltetradecanoyl)oxy]propoxy]phosphoryl}oxy)phosphinate; {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(12-methyltetradecanoyl)oxy]propoxy]phosphoryl}oxy)phosphinic acid; CDP-DG(28:0)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

CDP-DG(a-13:0/a-15:0). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000110287). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

CDP-DG(a-13:0/a-15:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(a-13:0/a-15:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids).

Entity Information

DBLinks

Other DBLinks
  • PubChem: 131822720
  • ChEBI: ChEBI:186929
  • HMDB: HMDB0116064

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0043969 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/a-15:0)
PathBank:SMP0043973 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/i-12:0)
PathBank:SMP0043977 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/i-16:0)
PathBank:SMP0043981 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/i-20:0)
PathBank:SMP0043985 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-13:0/18:2(9Z,11Z))
PathBank:SMP0043989 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-13:0/a-21:0)
PathBank:SMP0043993 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-13:0/i-14:0)
PathBank:SMP0043997 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-13:0/i-18:0)
PathBank:SMP0044001 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-13:0/i-22:0)
PathBank:SMP0044005 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-15:0/a-15:0)
PathBank:SMP0044009 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-15:0/i-12:0)
PathBank:SMP0044013 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-15:0/i-16:0)
PathBank:SMP0044017 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-15:0/i-20:0)
PathBank:SMP0044021 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-17:0/18:2(9Z,11Z))
PathBank:SMP0044025 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-17:0/a-21:0)
PathBank:SMP0044029 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-17:0/i-14:0)
PathBank:SMP0044033 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-17:0/i-18:0)
PathBank:SMP0044037 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-17:0/i-22:0)
PathBank:SMP0044041 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-21:0/a-15:0)
PathBank:SMP0044045 Cardiolipin Biosynthesis CL(a-13:0/a-15:0/a-21:0/i-12:0)
View All Pathways